These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3261810)

  • 1. [Cytokines and receptors--their functions, structures and cloning of code genes. Lymphotoxins].
    Kasakura S
    Nihon Rinsho; 1988 May; 46(5):1036-40. PubMed ID: 3261810
    [No Abstract]   [Full Text] [Related]  

  • 2. [Expectations in the clinical application of human-recombinant cytokines. 3) Tumor necrosis factor and lymphotoxins].
    Kawakami M
    Nihon Rinsho; 1988 May; 46(5):1099-104. PubMed ID: 3137380
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cytokines and receptors--their functions, structures and cloning of code genes. Tumor necrosis factor].
    Niitsu Y; Watanabe N
    Nihon Rinsho; 1988 May; 46(5):1041-9. PubMed ID: 2842520
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cytokines and receptors--their functions, structures and cloning of code genes. Macrophage activating factor].
    Taniyama T
    Nihon Rinsho; 1988 May; 46(5):1056-61. PubMed ID: 3137378
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biotherapy of cancer].
    Subirá ML; Brugarolas A
    Rev Clin Esp; 1992 Jun; 191(2):102-8. PubMed ID: 1380172
    [No Abstract]   [Full Text] [Related]  

  • 6. Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin.
    Bialas T; Kolitz J; Levi E; Polivka A; Oez S; Miller G; Welte K
    Cancer Res; 1988 Feb; 48(4):891-8. PubMed ID: 3257413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of a cytostatic lymphokine produced by incubation of lymphocytes with tumor cells: relationship to leukoregulin and distinction from recombinant lymphotoxin, recombinant tumor necrosis factor, and natural killer cytotoxic factor.
    Sayers TJ; Ransom JH; Denn AC; Herberman RB; Ortaldo JR
    J Immunol; 1986 Jul; 137(1):385-90. PubMed ID: 2423611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor, lymphotoxin and cancer.
    Drutskaya MS; Efimov GA; Kruglov AA; Kuprash DV; Nedospasov SA
    IUBMB Life; 2010 Apr; 62(4):283-9. PubMed ID: 20155809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy of cancer.
    Rosenberg SA
    Important Adv Oncol; 1992; ():17-38. PubMed ID: 1582673
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymphotoxins: a multicomponent system of cell-lytic lymphocyte-released effector molecules.
    Granger GA; Yamamoto RS; Devlin JJ; Klostergaard J
    Lymphokine Res; 1982; 1(2):45-9. PubMed ID: 6985401
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphotoxin and tumour necrosis factor as possible mediators of an inflammatory response.
    Ciba Found Symp; 1987; 131():185-91. PubMed ID: 3330010
    [No Abstract]   [Full Text] [Related]  

  • 12. Human peripheral blood lymphocytes targeted with bispecific antibodies release cytokines that are essential for inhibiting tumor growth.
    Qian JH; Titus JA; Andrew SM; Mezzanzanica D; Garrido MA; Wunderlich JR; Segal DM
    J Immunol; 1991 May; 146(9):3250-6. PubMed ID: 1826709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphotoxin and tumor necrosis factor: qualitative and quantitative differences in their receptors and signal transduction in various cell types.
    Aggarwal BB
    Prog Clin Biol Res; 1990; 349():375-84. PubMed ID: 2169060
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor necrosis factor and lymphotoxin secretion by human natural killer cells leads to antiviral cytotoxicity.
    Paya CV; Kenmotsu N; Schoon RA; Leibson PJ
    J Immunol; 1988 Sep; 141(6):1989-95. PubMed ID: 2844893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphogenic and host protective functions executed by tumor necrosis factor receptors, lymphotoxin receptors and their ligands.
    Pfeffer K
    Eur Cytokine Netw; 2000 Sep; 11(3):514. PubMed ID: 11203200
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of the antitumor activities of human tumor necrosis factor-alpha and the comparison with other cytokines: induction of tumor-specific immunity.
    Palladino MA; Shalaby MR; Kramer SM; Ferraiolo BL; Baughman RA; Deleo AB; Crase D; Marafino B; Aggarwal BB; Figari IS
    J Immunol; 1987 Jun; 138(11):4023-32. PubMed ID: 3295044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF as immunomodulatory agent.
    Bonavida B
    Immunol Ser; 1992; 56():315-29. PubMed ID: 1550866
    [No Abstract]   [Full Text] [Related]  

  • 18. [Function, molecular structure and gene expression regulation of tumor necrosis factor and lymphotoxin].
    Higashi N
    Nihon Rinsho; 1992 Aug; 50(8):1939-44. PubMed ID: 1331566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of TNF and lymphotoxin on the hematopoietic system.
    Trinchieri G
    Immunol Ser; 1992; 56():289-313. PubMed ID: 1550864
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional discrepancies between tumor necrosis factor and lymphotoxin alpha explained by trimer stability and distinct receptor interactions.
    Schuchmann M; Hess S; Bufler P; Brakebusch C; Wallach D; Porter A; Riethmüller G; Engelmann H
    Eur J Immunol; 1995 Aug; 25(8):2183-9. PubMed ID: 7664782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.